1. Home
  2. ADCT vs IMXI Comparison

ADCT vs IMXI Comparison

Compare ADCT & IMXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • IMXI
  • Stock Information
  • Founded
  • ADCT 2011
  • IMXI 1994
  • Country
  • ADCT Switzerland
  • IMXI United States
  • Employees
  • ADCT N/A
  • IMXI N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • IMXI Retail: Computer Software & Peripheral Equipment
  • Sector
  • ADCT Health Care
  • IMXI Technology
  • Exchange
  • ADCT Nasdaq
  • IMXI Nasdaq
  • Market Cap
  • ADCT 380.2M
  • IMXI 414.7M
  • IPO Year
  • ADCT 2020
  • IMXI N/A
  • Fundamental
  • Price
  • ADCT $4.54
  • IMXI $14.89
  • Analyst Decision
  • ADCT Strong Buy
  • IMXI Buy
  • Analyst Count
  • ADCT 6
  • IMXI 5
  • Target Price
  • ADCT $7.80
  • IMXI $19.60
  • AVG Volume (30 Days)
  • ADCT 1.1M
  • IMXI 401.5K
  • Earning Date
  • ADCT 11-06-2025
  • IMXI 11-07-2025
  • Dividend Yield
  • ADCT N/A
  • IMXI N/A
  • EPS Growth
  • ADCT N/A
  • IMXI N/A
  • EPS
  • ADCT N/A
  • IMXI 1.65
  • Revenue
  • ADCT $77,246,000.00
  • IMXI $642,149,000.00
  • Revenue This Year
  • ADCT $13.47
  • IMXI N/A
  • Revenue Next Year
  • ADCT $5.88
  • IMXI $1.87
  • P/E Ratio
  • ADCT N/A
  • IMXI $9.06
  • Revenue Growth
  • ADCT 15.73
  • IMXI N/A
  • 52 Week Low
  • ADCT $1.05
  • IMXI $8.58
  • 52 Week High
  • ADCT $4.67
  • IMXI $22.37
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 74.76
  • IMXI 70.52
  • Support Level
  • ADCT $4.15
  • IMXI $13.94
  • Resistance Level
  • ADCT $4.67
  • IMXI $14.28
  • Average True Range (ATR)
  • ADCT 0.25
  • IMXI 0.15
  • MACD
  • ADCT 0.08
  • IMXI -0.04
  • Stochastic Oscillator
  • ADCT 82.86
  • IMXI 84.98

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

Share on Social Networks: